Successful treatment of a primary cutaneous zygomycosis caused by Absidia corymbifera in a premature newborn.
Mucormycosis (zygomycosis) normally occurs among individuals with predisposing factors such as prematurity, use of broad spectrum antibiotics, metabolic acidosis or advanced stages of immunosuppression. There have been reports of sporadic cases of cutaneous mucormycosis related to predisposing skin lesions and contact with contaminated material such as adhesive bandages and tongue depressors placed close to intravenous catheter insertion sites. We report successful treatment of a case of Absidia corymbifera infection with the combination of amphotericin B and surgical debridement of the affected area.
Morales-Aguirre
José Juan
JJ
Departments of Epidemiology, Hospital Infantil de México Federico Gómez, México City, México.
Agüero-Echeverría
Wilson Martín
WM
Ornelas-Carsolio
María Elena
ME
Reséndiz-Sánchez
Jesús
J
Gómez-Barreto
Demóstenes
D
Cashat-Cruz
Miguel
M
D020095:Absidia / Q000187:drug effects / Q000302:isolation & purification; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003646:Debridement / Q000379:methods; D003881:Dermatomycoses / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery*; D009091:Mucormycosis / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery; D016896:Treatment Outcome
D000935:Antifungal Agents; D000666:Amphotericin B